Your browser doesn't support javascript.
loading
Osteoblast-derived vesicles induce a switch from bone-formation to bone-resorption in vivo.
Uenaka, Maki; Yamashita, Erika; Kikuta, Junichi; Morimoto, Akito; Ao, Tomoka; Mizuno, Hiroki; Furuya, Masayuki; Hasegawa, Tetsuo; Tsukazaki, Hiroyuki; Sudo, Takao; Nishikawa, Keizo; Okuzaki, Daisuke; Motooka, Daisuke; Kosaka, Nobuyoshi; Sugihara, Fuminori; Boettger, Thomas; Braun, Thomas; Ochiya, Takahiro; Ishii, Masaru.
Afiliação
  • Uenaka M; Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, Osaka, Japan.
  • Yamashita E; Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, Osaka, Japan.
  • Kikuta J; Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, Osaka, Japan. jkikuta@icb.med.osaka-u.ac.jp.
  • Morimoto A; WPI-Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan. jkikuta@icb.med.osaka-u.ac.jp.
  • Ao T; Laboratory of Bioimaging and Drug Discovery, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan. jkikuta@icb.med.osaka-u.ac.jp.
  • Mizuno H; Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, Osaka, Japan.
  • Furuya M; Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, Osaka, Japan.
  • Hasegawa T; Laboratory of Bioimaging and Drug Discovery, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan.
  • Tsukazaki H; Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, Osaka, Japan.
  • Sudo T; WPI-Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan.
  • Nishikawa K; Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, Osaka, Japan.
  • Okuzaki D; Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, Osaka, Japan.
  • Motooka D; Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, Osaka, Japan.
  • Kosaka N; Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, Osaka, Japan.
  • Sugihara F; WPI-Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan.
  • Boettger T; Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, Osaka, Japan.
  • Braun T; WPI-Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan.
  • Ochiya T; Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
  • Ishii M; Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Nat Commun ; 13(1): 1066, 2022 02 24.
Article em En | MEDLINE | ID: mdl-35210428
ABSTRACT
Bone metabolism is regulated by the cooperative activity between bone-forming osteoblasts and bone-resorbing osteoclasts. However, the mechanisms mediating the switch between the osteoblastic and osteoclastic phases have not been fully elucidated. Here, we identify a specific subset of mature osteoblast-derived extracellular vesicles that inhibit bone formation and enhance osteoclastogenesis. Intravital imaging reveals that mature osteoblasts secrete and capture extracellular vesicles, referred to as small osteoblast vesicles (SOVs). Co-culture experiments demonstrate that SOVs suppress osteoblast differentiation and enhance the expression of receptor activator of NF-κB ligand, thereby inducing osteoclast differentiation. We also elucidate that the SOV-enriched microRNA miR-143 inhibits Runt-related transcription factor 2, a master regulator of osteoblastogenesis, by targeting the mRNA expression of its dimerization partner, core-binding factor ß. In summary, we identify SOVs as a mode of cell-to-cell communication, controlling the dynamic transition from bone-forming to bone-resorbing phases in vivo.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteogênese / Reabsorção Óssea Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteogênese / Reabsorção Óssea Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Ano de publicação: 2022 Tipo de documento: Article